Unknown

Dataset Information

0

CD47-targeting antibodies as a novel therapeutic strategy in hematologic malignancies.


ABSTRACT: CD47 is a surface glycoprotein expressed by host cells to impede phagocytosis upon binding to macrophage SIRPα, thereby represents an immune checkpoint known as the "don't-eat-me" signal. However, accumulating evidence shows that solid and hematologic tumor cells overexpress CD47 to escape immune surveillance. Thus, targeting the CD47-SIRPa axis by limiting the activity of this checkpoint has emerged as a key area of research. In this review, we will provide an update on the landscape of CD47-targeting antibodies for hematological malignancies, including monoclonal and bi-specific antibodies, with a special emphasis on agents in clinical trials and novel approaches to overcome toxicity.

SUBMITTER: Sun J 

PROVIDER: S-EPMC8455363 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC2844014 | biostudies-literature
| S-EPMC5856170 | biostudies-literature
| S-EPMC6990910 | biostudies-literature
| S-EPMC3482854 | biostudies-other
2024-06-22 | PXD043213 | Pride
| S-EPMC4277117 | biostudies-literature
| S-EPMC6766786 | biostudies-literature
| S-EPMC4152229 | biostudies-literature
| S-EPMC10566133 | biostudies-literature
| S-EPMC5528671 | biostudies-other